The Crux Biomedical IVCF was designed to address the limitations of currently available vena cava filters including perforation, migration and inability to retrieve.

[read more]

At the one year mark, 100% of the great saphenous vein segments treated with this vein sealant remained completely closed by ultrasound criteria.

[read more]

The Vascular Disease Foundation describes risk factors, warning signs and symptoms, treatment and prevention of deep vein thrombosis or DVT.

[read more]

Patrick Peeters, Bonheiden, Belgium, speaks about the right mix to make bioabsorbable drug-eluting stents, potential benefits, and challenges in the peripheral and coronary arteries treatment.

[read more]

Jörn Oliver Balzer, Mainz, Germany, reviewed up-to-date research on vena cava filters and their effectiveness to prevent pulmonary embolism.

[read more]

Regula von Allmen, vascular research fellow, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, UK, wrote to Vascular News an article based on the discussions from the chronic cerebrospinal venous insufficiency (CCSVI) session presented at the VEITHsymposium.

[read more]

Patrick Peeters, chief, Department of Cardiovascular Surgery, Imelda Hospital, Bonheiden, Belgium, specialist in cardiac, thoracic and vascular surgery, told Vascular News how endovascular therapies have changed his career and their influence on his proudest moments. He also explained how the clinical research project he founded with Marc Bosiers works.

[read more]

Charles McCollum, University of Manchester, UK, spoke to Vascular News about his career, the area of vascular surgery that fascinates him most, the evolution of the field and the lessons he has learnt from two memorable cases.

[read more]